Bristol Myers Squibb Company
430 E. 29th St
14th Floor
New York
New York
10016
United States
Tel: +1-800-332-2056
Website: http://www.bms.com/
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time. Our focus on these unmet needs comes during a remarkable time, when unprecedented scientific breakthroughs are advancing the treatment of disease as never before in human history.
We work every day to transform patients’ lives through science. Each day, our employees around the world work together for patients – they are at the center of everything we do. They inspire us. They are the reason we come to work each day.
We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.
Possibility Lives at BMS!
2899 articles about Bristol Myers Squibb Company
-
Bristol-Myers Squibb Company Submits Letter to ImClone Systems Incorporated Board of Directors
9/11/2008
-
Bristol-Myers Squibb Company Announces Dividend
9/10/2008
-
Accenture Announces $550 Million, 10-year Agreement with Bristol-Myers Squibb Company
9/10/2008
-
Bristol-Myers Squibb Company, AstraZeneca PLC Meet Study Goal
9/9/2008
-
Albany Molecular Research, Inc. to Receive $1.5M from Bristol-Myers Squibb Company
9/9/2008
-
Second Compound from Albany Molecular Research, Inc. Bristol-Myers Squibb Company Collaboration Selected for Preclinical Development
9/8/2008
-
Bristol-Myers Squibb Company, AstraZeneca PLC Diabetes Pill Promising in Studies
9/8/2008
-
Bristol-Myers Squibb Company and AstraZeneca PLC to Hold Investor Teleconference to Discuss EASD Highlights
9/3/2008
-
Bristol-Myers Squibb Company, Pfizer Inc. Drug Ups Bleeding in Heart Study
9/2/2008
-
Bristol-Myers Squibb Company and Pfizer Inc. Release: New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients
9/2/2008
-
Bristol-Myers Squibb Company (JOBS) Welcomes NICE Guidance Recommending Baraclude(R) (entecavir) as a Treatment Option for Chronic Hepatitis B
8/29/2008
-
Bristol-Myers Squibb Company to Hold Investor Teleconference to Discuss ESC Highlights
8/28/2008
-
Bristol-Myers Squibb Company (JOBS), Pfizer Inc. (JOBS) to Delay Clot Drug after Setback
8/27/2008
-
Bristol-Myers Squibb Company (JOBS) and PDL BioPharma, Inc. Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma; PDL BioPharma Receive Upfront Cash $30 Million
8/20/2008
-
Tekmira Pharmaceuticals Corporation Announces RNAi Research Collaboration With Bristol-Myers Squibb Company (JOBS)
8/13/2008
-
Bristol-Myers Squibb Company Release: CASTLE Data Showed Boosted REYATAZ(R) (atazanavir sulfate) and Lopinavir/r Achieved Similar Results for Undetectable Viral Load in Treatment-Naive HIV-1 Infected Patients, Regardless of Gender
8/5/2008
-
Bristol-Myers Squibb Company Launches Secure the Future(R) Technical Assistance Program to Optimize Community Services for Comprehensive HIV Management in Sub-Suharan Africa
8/5/2008
-
Bristol-Myers Squibb Company (JOBS) Says Has Rights to Erbitux Successor
8/5/2008
-
Bristol-Myers Squibb Company Announces Completion of ConvaTec Divestiture
8/1/2008
-
Bristol-Myers Squibb Company (JOBS) Offers to Buy ImClone Systems Incorporated (JOBS) for $60 a Share
7/31/2008